Clinical trials
Withdrawn Phase 2 Carcinoma, Merkel Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4SC AG | 1 |
| Burzynski Research Institute | 1 |
| Excel Diagnostics and Nuclear Oncology Center | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 4 |
| Carcinoma, Islet Cell | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Growth Hormone-Secreting Pituitary Adenoma | 1 |
| Neoplasms, Unknown Primary | 1 |
| Neuroendocrine Tumors | 1 |
| Paraganglioma | 1 |
| Pheochromocytoma | 1 |
| Pituitary Neoplasms | 1 |
| Somatostatinoma | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.